What Is Circular RNA and Why Does It Matter?

RNA has become an important part of modern biotechnology. Most people became familiar with messenger RNA (mRNA) through vaccines, but scientists are also studying another form of RNA with a very different structure: circular RNA.

So, what is circular RNA, and why are researchers so interested in it?

Circular RNA, commonly called circRNA, is a single-stranded RNA molecule whose ends are joined together to form a continuous loop. Unlike conventional linear RNA, it does not have exposed 5′ and 3′ ends.

That structural difference matters. The closed-loop design can make circular RNA more resistant to certain forms of enzymatic degradation than linear RNA. Naturally occurring circRNAs can also take part in gene regulation, interact with proteins and microRNAs, and, in some cases, serve as templates for protein production.

These properties have made circular RNA an active area of research across molecular biology, vaccines, therapeutics, diagnostics, and cancer research.

For an RNA vaccine biotechnology company, understanding and engineering RNA structure may open new ways to design vaccines and other RNA-based technologies.

What Is Circular RNA?

To understand what is circular RNA, it helps to first understand conventional RNA.

Most RNA molecules people hear about are linear. They have a beginning and an end, often described as the 5′ end and 3′ end.

Circular RNA is different.

Its ends are covalently joined, creating a closed loop.

In simple terms:

Linear RNA:
5′ → RNA sequence → 3′

Circular RNA:
RNA sequence → closed loop → no free ends

This may appear to be a small structural change, but it gives circRNA properties that distinguish it from conventional linear RNA.

Circular RNAs occur naturally in cells and were once often viewed as unusual products of RNA processing. Advances in RNA sequencing and molecular biology have shown that many circRNAs are biologically relevant and can perform different regulatory functions.

What Does Circular RNA Structure Look Like?

The circular RNA structure is defined by its covalently closed loop.

Unlike conventional messenger RNA, circRNA generally lacks the free ends found on linear RNA molecules.

Why does that matter?

Some enzymes break down RNA by attacking its exposed ends. Because circular RNA has no free ends, its structure can make it more resistant to certain exonucleases.

This structural stability is one reason circRNA has attracted interest as a possible platform for biotechnology and medicine.

How Is Circular RNA Formed?

Many naturally occurring circular RNAs are produced through a process known as back-splicing.

During normal RNA processing, sections of precursor RNA are joined together to produce mature RNA.

With back-splicing, a downstream splice site joins to an upstream splice site. This creates a circular molecule instead of a conventional linear transcript.

Depending on how they are formed, naturally occurring circRNAs can contain:

• Exons
• Introns
• Both exons and introns

Researchers can also engineer circular RNA molecules for specific scientific or therapeutic purposes.

Circular RNA vs. Linear mRNA

The easiest way to understand why circRNA has attracted attention is to compare it with linear mRNA.

Feature	Circular RNA	Linear mRNA
Structure	Closed loop	Linear strand
Free 5′ and 3′ ends	No	Yes
Resistance to some exonucleases	Generally higher	Generally lower
Naturally found in cells	Yes	Yes
Can regulate biological processes	Yes	Yes
Can potentially encode proteins	Some circRNAs	Yes
Being studied for engineered therapeutics	Yes	Yes

This does not mean circular RNA is simply a “better version” of mRNA.

The two RNA formats have different biological properties, manufacturing requirements, delivery challenges, and potential applications.

Why Is Circular RNA More Stable?

One of the most studied characteristics of circular RNA is its stability.

Linear RNA contains exposed ends that can be recognized by enzymes involved in RNA degradation. The closed-loop structure of circRNA removes these free ends and can make the molecule less vulnerable to certain exonucleases.

Greater molecular stability could be valuable when researchers want RNA activity to persist for longer periods.

However, stability depends on more than shape alone. Sequence design, RNA modifications, delivery systems, cell type, manufacturing methods, and the surrounding biological environment can all affect how an engineered RNA behaves.

What Does Circular RNA Do in the Body?

Naturally occurring circRNAs can perform several biological functions.

Researchers have identified circRNAs involved in gene regulation, cellular signaling, protein interactions, and other biological processes.

Some of their studied functions include:

Interacting With MicroRNAs

Some circRNAs contain binding sites for microRNAs.

By interacting with these molecules, circRNAs may influence how microRNAs regulate gene expression.

This is sometimes described as acting as a “microRNA sponge.”

Not every circRNA works this way, however, and the biological importance depends on the specific molecule and cellular context.

Interacting With Proteins

Circular RNAs can also bind to proteins.

These interactions may influence:

• Protein activity
• Protein localization
• Cellular signaling
• Gene regulation

Some circRNAs may function as scaffolds that bring different molecules together.

Regulating Gene Expression

Certain circRNAs can influence transcription, RNA processing, or other parts of gene regulation.

Because different circRNAs may be expressed in different tissues or developmental stages, researchers are studying how these molecules contribute to normal biology and disease.

Producing Proteins

Circular RNA was once discussed mainly as a form of noncoding RNA.

Research has since shown that some circRNAs can be translated into proteins or peptides under the right conditions.

This finding is particularly important for biotechnology.

If scientists can engineer circular RNA to produce a selected protein efficiently, the platform could potentially be used for vaccines and other therapeutic applications.

Why Does Circular RNA Matter for Biotechnology?

Circular RNA combines several properties that make it scientifically interesting:

1. A closed-loop molecular structure
2. Resistance to certain RNA-degrading enzymes
3. Potential for sustained biological activity
4. Ability to interact with cellular machinery
5. Potential use as an engineered protein-expression platform

Together, these characteristics have encouraged researchers to explore circRNA across several areas of medicine.

Circular RNA and Vaccine Technology

Vaccines can work by teaching the immune system to recognize a specific antigen associated with a pathogen.

RNA vaccine platforms can deliver genetic instructions that allow cells to temporarily produce that antigen. The immune system can then learn to recognize it.

Engineered circular RNA is being investigated as another way to deliver those instructions.

The potential advantages being studied include:

• RNA stability
• Duration of antigen expression
• Dose efficiency
• Manufacturing possibilities
• Different delivery approaches

These characteristics are helping drive research into Circular RNA Vaccine Technology.

The important distinction is that circRNA vaccine platforms are still an evolving area of biotechnology. Their performance depends on the RNA design, antigen, formulation, delivery method, dose, and disease target.

Why Could Circular RNA Matter for Infectious Diseases?

Emerging infectious diseases create several challenges for vaccine development.

Researchers may need platforms that can be:

• Designed quickly
• Adapted to new pathogens
• Manufactured efficiently
• Distributed at scale
• Capable of producing a useful immune response

RNA platforms are attractive because the genetic sequence encoding a target antigen can potentially be changed without redesigning the entire platform from scratch.

Circular RNA adds another approach to this field because of its structural properties and potential for durable expression.

Vaxxirna’s infectious disease programs are focused on applying RNA-based technology to the development of vaccines against infectious-disease targets.

Could Circular RNA Help Improve Vaccine Access?

Vaccine effectiveness is only one part of global vaccination.

Storage and distribution also matter.

Some vaccine technologies require tightly controlled temperatures throughout transportation and storage. Maintaining this “cold chain” can be difficult and expensive, particularly in areas with limited infrastructure.

For engineered circRNA platforms, researchers are therefore interested not only in biological performance but also in formulation, storage, delivery, and manufacturing.

If an RNA vaccine platform can ultimately be formulated with practical storage and distribution characteristics, it could potentially reduce some logistical barriers.

These benefits must be demonstrated for each specific formulation rather than assumed from circular RNA structure alone.

Circular RNA in Cancer

Circular RNA in cancer is another major research area, but it is different from developing circRNA vaccines for infectious diseases.

Researchers have found that the expression of certain naturally occurring circRNAs can change in cancer cells.

Some circRNAs have been associated with biological processes related to:

• Cell growth
• Cell death
• Tumor progression
• Metastasis
• Gene regulation
• Treatment response

Because circRNAs can be relatively stable and may show tissue-specific expression patterns, scientists are investigating whether certain molecules could eventually serve as biomarkers.

Could Circular RNA Be Used as a Cancer Biomarker?

A biomarker is a measurable biological characteristic that can provide information about a disease or biological process.

Researchers have detected circRNAs in tissues and body fluids, including blood, saliva, and urine.

Their relative stability makes them interesting candidates for research into:

• Cancer detection
• Disease classification
• Prognosis
• Treatment monitoring

However, identifying a circRNA associated with cancer does not automatically make it a clinically useful biomarker.

Potential biomarkers require careful validation for accuracy, sensitivity, specificity, reproducibility, and clinical usefulness.

Could Circular RNA Be Used to Treat Cancer?

Scientists are also studying whether circRNA biology could be used therapeutically.

Potential research directions include:

• Targeting disease-associated circRNAs
• Using engineered circRNA to produce therapeutic proteins
• Modifying immune responses
• Developing RNA-based therapeutic systems

This field remains under active investigation.

Circular RNA research has expanded rapidly, but many proposed cancer applications are still at preclinical or early translational stages.

Natural Circular RNA vs. Engineered Circular RNA

An important distinction is often missed when discussing what is circular RNA.

There are two broad contexts:

Natural circRNA

These molecules are produced naturally inside cells and can participate in biological processes.

Engineered circRNA

Scientists can design and manufacture circular RNA for research or potential therapeutic applications.

The goals are very different.

Researchers studying natural circRNA may be trying to understand disease biology or identify biomarkers.

Researchers engineering circRNA may instead be trying to create a molecule that produces a specific protein or antigen.

Why Delivery Still Matters

A stable RNA molecule is not enough by itself.

For engineered RNA to work, it must reach the right cells and perform its intended function.

Researchers therefore have to consider:

• How the RNA enters cells
• Which cells receive it
• How much RNA reaches the target
• How long expression lasts
• How the immune system responds
• Whether the delivery method is safe and practical

Delivery remains one of the central challenges across RNA medicine.

What Are the Challenges of Circular RNA Technology?

Circular RNA has promising characteristics, but significant scientific and technical questions remain.

Manufacturing

Producing engineered circRNA consistently and at scale requires controlled manufacturing and purification processes.

Purity

Manufacturing can generate unwanted RNA species or other byproducts that need to be identified and removed.

Translation Efficiency

A circular molecule does not use exactly the same translation mechanisms as conventional capped mRNA. Engineered designs therefore need effective ways to initiate protein production.

Delivery

RNA still needs an effective delivery method to reach target cells.

Immune Response

Researchers must understand both the intended immune response and any unwanted innate immune activation associated with a particular construct or formulation.

Clinical Validation

Promising laboratory or animal results do not guarantee success in humans.

Safety, dose, immune response, durability, and effectiveness ultimately need to be established through appropriate clinical studies.

Why Circular RNA Matters for the Future of RNA Medicine

The growing interest in circular RNA comes from a simple structural difference with potentially important biological consequences.

Closing an RNA molecule into a loop can change its stability and behavior.

That creates opportunities to explore new approaches to:

• Vaccination
• Protein expression
• Infectious disease prevention
• Therapeutics
• Biomarkers
• Cancer research

But the field should be viewed with scientific care.

Circular RNA is not one product, and the properties of one circRNA platform cannot automatically be applied to every other circular RNA molecule.

Sequence, manufacturing, formulation, delivery, dose, and disease target all matter.

Vaxxirna and Circular RNA Research

Vaxxirna is developing RNA-based vaccine technologies with a focus on infectious diseases.

Its work explores how circular RNA design can be combined with vaccine development and delivery approaches to address challenges associated with current vaccine platforms.

As research progresses, circular RNA could provide another important tool for designing vaccines that are practical, scalable, and capable of addressing infectious-disease threats.

Final Thoughts

So, what is circular RNA?

Circular RNA is an RNA molecule with a covalently closed-loop structure rather than the free ends found in conventional linear RNA.

That structure can provide greater resistance to certain forms of RNA degradation and creates biological properties that researchers are studying across vaccines, therapeutics, diagnostics, and cancer biology.

The importance of circular RNA goes beyond its shape. Researchers are learning how its structure affects stability, gene regulation, protein production, and potential medical applications.

For vaccine biotechnology in particular, engineered circRNA offers an emerging platform worth studying for infectious-disease prevention and other areas of medicine.

As with any developing technology, its ultimate impact will depend on rigorous research, reproducible manufacturing, effective delivery, and clinical evidence.

FAQs

What is circular RNA?

Circular RNA, or circRNA, is a single-stranded RNA molecule with a covalently closed-loop structure. Unlike linear RNA, it does not have free 5′ and 3′ ends.

What is special about circular RNA structure?

The closed-loop circular RNA structure makes circRNA resistant to certain enzymes that degrade RNA from exposed ends. This can give circRNA greater stability than comparable linear RNA molecules.

How is circular RNA different from mRNA?

Conventional mRNA is linear and has 5′ and 3′ ends, while circRNA forms a continuous loop. Both can interact with cellular machinery, and appropriately designed forms can support protein production, but their structure, translation mechanisms, stability, and other properties differ.

Can circular RNA make proteins?

Some natural circRNAs can be translated, and engineered circRNAs can be designed to produce selected proteins. This capability is one reason researchers are exploring circRNA for vaccines and therapeutics.

What is the role of circular RNA in cancer?

Researchers have found changes in the expression and function of certain circRNAs in multiple cancers. Studies are investigating their roles in cancer biology and their potential use as biomarkers or therapeutic targets, but many clinical applications remain experimental.

Why is circular RNA being studied for vaccines?

Engineered circRNA is being studied because its closed-loop structure can support increased RNA stability and potentially prolonged antigen expression. Researchers are investigating whether these properties can improve future RNA vaccine platforms.